208 related articles for article (PubMed ID: 19893914)
1. [Use of insulin glargine in type 1 diabetes children with less than eight years old].
Rollin G; Punales M; Geremia C; Ce GV; Tschiedel B
Arq Bras Endocrinol Metabol; 2009 Aug; 53(6):721-5. PubMed ID: 19893914
[TBL] [Abstract][Full Text] [Related]
2. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
[TBL] [Abstract][Full Text] [Related]
4. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
5. [Switching of NPH insulin to glargine therapy in a cohort of diabetic patients: observational study].
Maia FF; Melo FJ; Araújo IM; Araújo LR
Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):426-30. PubMed ID: 17546241
[TBL] [Abstract][Full Text] [Related]
6. [Insulin glargine improves fasting blood glucose levels in prepubertal children with unsatisfactorily controlled type 1 diabetes].
Mianowska B; Szadkowska A; Czerniawska E; Pietrzak I; Bodalski J
Pediatr Endocrinol Diabetes Metab; 2007; 13(4):189-93. PubMed ID: 18042313
[TBL] [Abstract][Full Text] [Related]
7. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.
Schober E; Schoenle E; Van Dyk J; Wernicke-Panten K;
Diabetes Care; 2001 Nov; 24(11):2005-6. PubMed ID: 11679478
[No Abstract] [Full Text] [Related]
8. [Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy].
Pesić M; Zivić S; Radenković S; Velojić M; Dimić D; Antić S
Vojnosanit Pregl; 2007 Apr; 64(4):247-52. PubMed ID: 17580534
[TBL] [Abstract][Full Text] [Related]
9. The rate of improvement in metabolic control in children with diabetes mellitus type 1 on insulin glargine depends on age.
Deja G; Jarosz-Chobot P; Polanska J
Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):662-8. PubMed ID: 18058601
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of insulin degludec and insulin glargine over NPH insulin among toddlers and preschoolers with type 1 diabetes using glycemic variability and time in range.
Elhabashy SA; Sakr EM; Salah NY
Eur J Pediatr; 2023 Apr; 182(4):1857-1868. PubMed ID: 36800034
[TBL] [Abstract][Full Text] [Related]
11. Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
Duckworth W; Davis SN
J Diabetes Complications; 2007; 21(3):196-204. PubMed ID: 17493554
[TBL] [Abstract][Full Text] [Related]
12. Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes.
Garg SK; Paul JM; Karsten JI; Menditto L; Gottlieb PA
Diabetes Technol Ther; 2004 Oct; 6(5):589-95. PubMed ID: 15628812
[TBL] [Abstract][Full Text] [Related]
13. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
Rosenstock J; Dailey G; Massi-Benedetti M; Fritsche A; Lin Z; Salzman A
Diabetes Care; 2005 Apr; 28(4):950-5. PubMed ID: 15793205
[TBL] [Abstract][Full Text] [Related]
14. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
Tan CY; Wilson DM; Buckingham B
Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
[TBL] [Abstract][Full Text] [Related]
15. Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus.
Chase HP; Arslanian S; White NH; Tamborlane WV
J Pediatr; 2008 Oct; 153(4):547-53. PubMed ID: 18589448
[TBL] [Abstract][Full Text] [Related]
16. A randomized cross-over trial to identify the optimal use of insulin glargine in prepubertal children using a three-times daily insulin regimen.
Fröhlich-Reiterer EE; Ong KK; Regan F; Salzano G; Acerini CL; Dunger DB
Diabet Med; 2007 Dec; 24(12):1406-11. PubMed ID: 18042082
[TBL] [Abstract][Full Text] [Related]
17. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
Rosenstock J; Park G; Zimmerman J;
Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
[TBL] [Abstract][Full Text] [Related]
18. Insulin glargine versus NPH insulin in patients with type 1 diabetes.
Ratner R
Drugs Today (Barc); 2003 Nov; 39(11):867-76. PubMed ID: 14702132
[TBL] [Abstract][Full Text] [Related]
19. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
[TBL] [Abstract][Full Text] [Related]
20. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
Riddle MC; Rosenstock J; Gerich J;
Diabetes Care; 2003 Nov; 26(11):3080-6. PubMed ID: 14578243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]